Weed (BUDZ) Operating Income (2010 - 2026)
Weed's (BUDZ) quarterly Operating Income came in at -$163955.0 in Q1 2026, up 62.29% year-on-year from -$101028.2 in Q1 2025, and up 77.44% quarter-over-quarter from -$726874.0 in Q4 2025.
Weed (BUDZ) Operating Income (2010 - 2026) Analysis & Trends
Weed's Operating Income history runs 13 years deep, the most recent figure standing at -$163955.0 for Q1 2026.
- On a quarterly basis, Operating Income rose 62.29% year-over-year to -$163955.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 31.5% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 150.51% from the prior year.
- Operating Income rose to -$163955.0 in Q1 2026 per BUDZ's latest filing, from -$726874.0 in the prior quarter.
- Across five years, Operating Income topped out at -$32746.0 in Q4 2023 and bottomed at -$726874.0 in Q4 2025.
- The 5-year median for Operating Income is -$167489.0 (2024), against an average of -$243292.8.
- Across the five-year window, Operating Income soared 88.66% in 2023 and slumped 470.27% in 2025, its largest moves.
- Year by year, Operating Income stood at -$288861.0 in 2022, then surged by 88.66% to -$32746.0 in 2023, then sank by 289.24% to -$127462.0 in 2024, then slumped by 470.27% to -$726874.0 in 2025, then surged by 77.44% to -$163955.0 in 2026.
- Per Business Quant, the three latest BUDZ Operating Income figures stand at -$163955.0 (Q1 2026), -$726874.0 (Q4 2025), and -$66897.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -163,955.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163,955.00 |
| Dec 31, 2025 | -726,874.00 |
| Sep 30, 2025 | -66,897.00 |
| Jun 30, 2025 | -94,045.00 |
| Mar 31, 2025 | -434,737.00 |
| Dec 31, 2024 | -127,462.00 |
| Sep 30, 2024 | -92,649.00 |
| Jun 30, 2024 | -144,955.00 |
| Mar 31, 2024 | -167,489.00 |
| Dec 31, 2023 | -32,746.00 |
| Sep 30, 2023 | -238,824.00 |
| Jun 30, 2023 | -156,163.00 |
| Mar 31, 2023 | -183,908.00 |
| Dec 31, 2022 | -288,861.00 |
| Sep 30, 2022 | -277,960.00 |
| Jun 30, 2022 | -407,313.00 |
| Mar 31, 2022 | -531,140.00 |
| Dec 31, 2021 | -461,338.00 |
| Sep 30, 2021 | -169,910.00 |
| Jun 30, 2021 | -1.21 Mn |